BIPROGY (8056) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
20 Oct, 2026Executive summary
H1 FYMar2024 revenue rose 11.8% YoY to ¥173.0B; operating profit increased 21.9% to ¥16.6B, supported by System Services and product sales.
Orders rose to ¥166.3B and order backlog to ¥267.2B, with strength in System Services and outsourcing.
Financial highlights
Revenue was ¥173.0B vs. ¥154.8B YoY; gross profit was ¥46.2B vs. ¥41.4B, while SG&A expenses increased to ¥29.7B from ¥27.8B.
Operating profit reached ¥16.6B vs. ¥13.6B; profit attributable to owners of parent was ¥12.8B vs. ¥10.1B.
Adjusted operating profit was ¥16.5B vs. ¥13.6B, up 21.6% YoY.
Outlook and guidance
FYMar2024 forecast remained unchanged: revenue ¥350.0B, operating profit ¥32.5B, profit attributable to owners of parent ¥22.0B and adjusted operating profit ¥32.0B.
Current assessment indicated no risks expected to significantly affect H2 performance.
Latest events from BIPROGY
- Q1 operating profit rose 22% as revenue, orders, and backlog grew.8056
Q1 2024 - Strong DX demand lifted FYMar2024 results; growth investment supports FYMar2025 expansion.8056
Q4 2024 - 9M revenue and operating profit grew; full-year forecasts and dividends rose.8056
Q3 2024 - Deferred product sales cut Q1 profit, while orders surged and FY2027 guidance stayed unchanged.8056
Q1 2027 - Q1 revenue and operating profit grew, with full-year guidance unchanged.8056
Q1 2025 - Revenue and operating profit rose, but net profit declined; full-year guidance was unchanged.8056
Q2 2025 - Revenue and orders grew, lifting the FY revenue forecast despite lower net profit.8056
Q3 2025 - Revenue and operating profit grew; FY2027 revenue target rose to ¥440bn.8056
Q4 2025 - Q1 revenue and profit grew; full-year guidance remains unchanged.8056
Q1 2026